Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neurofibrosarcoma × Ipilimumab × Clear all

Sponsor

Conditions

Melanoma 79 Carcinoma, Non-Small-Cell Lung 25 Neoplasms 18 Neoplasm Metastasis 13 Carcinoma, Renal Cell 13 Lung Neoplasms 11 Small Cell Lung Carcinoma 9 Prostatic Neoplasms 9 Diabetes Mellitus, Insulin-Dependent, 12 8 Pancreatic Neoplasms 7 Skin Neoplasms 6 Ovarian Neoplasms 6 Uveal Melanoma 5 Squamous Cell Carcinoma of Head and Neck 5 Mesothelioma 5 Brain Neoplasms 5 Sarcoma 4 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Colonic Neoplasms 3

Interventions

Doxorubicin 4 pazopanib 3 Ifosfamide 3 Sorafenib 2 Sirolimus 2 Radiotherapy 2 Etoposide 2 thymoglobulin 1 temsirolimus 1 tazemetostat 1 romidepsin 1 pexidartinib 1 lorvotuzumab mertansine 1 liposomal doxorubicin 1 indolepropanol phosphate 1 fludarabine phosphate 1 Watchful Waiting 1 Thiotepa 1 Tacrolimus 1 Sunitinib 1 Stem Cell Transplantation 1 STA 9090 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡